Medical net on June 28 the thing is something wrong!
Baeyer, baiyun mountain, shenwei, Beijing novartis, north China pharmaceutical, xi 'an lijun and other 192 pharmaceutical companies called the "retreat", applying 495 products to the waste standard, not in these two provinces to sell!
▍ 424 drugs were limit, apply for withdrawal
On June 27, sichuan province's centralized procurement service center issued a notice: the company voluntarily applied to withdraw 424 products from the network to cancel the network. In this procurement cycle, the above - withdrawal drug declaration and network work shall not be accepted.
Most of the 424 products in sichuan province have been used for the treatment of children, such as aminophenol xanthin and cephaloxil capsules, including the large infusion. It is surprising that such products should exit the market. The reason is clear: these products are a regular online price limit.
On the same day, the gansu public resources trading network issued a notice on the cancellation of the qualification of some medicines, and agreed to apply for the withdrawal of 71 products from 22 pharmaceutical companies. (see annex for details)
▍ - main products disappear in the bottom of the price, raw material prices
The evacuation of sichuan and gansu provinces has attracted the attention of the industry. Sichuan is large and gansu is more frequent.
This is the 16th such notice in gansu province. The reason for the withdrawal of each batch of pharmaceutical companies is the same: manufacturers discontinue production, production lines and costs rise. In the back of these written arguments, there is still price and profit.
It is necessary to understand the market for drug companies to abandon the price depressions if they are in the middle of the bidding season and have a killer "price linkage". And the szechuan 424 drug withdrawal standard better understand, the price limit, no profit, simply not sell!
From the point of view of maintaining price in the company's overall consideration, it is reasonable to give up some of the market, and the decision to lose the car is reasonable, but it is a little too fierce.
▍ lawmaker said senior leadership attaches great importance to
The fact that the price of a drug is "erased" from the market is caused by the rising cost of the raw material monopoly. Every time, it hurts the nerves of all sectors of society -- the unavailability of drugs or the expensive alternatives that impact the outcome of health reform.
Leaders pay close attention to these issues.
According to the Beijing news reported, on June 26, in the afternoon, the standing committee of the National People's Congress group review about drug administration under the state council work report, the pharmaceutical administration law enforcement inspection report, strict to the new, gu shengzu, Shi Lianxi committee of the NPC standing committee are about drug shortage, the imbalance of supply and demand.
, vice chairman of the standing committee of the National People's Congress Chen zhu said that "the current some cheap drugs, including a number of emergency medicine and some important diseases of the shortage of national basic drugs, the resulting drug accessibility problem is very outstanding, endanger the patient lives. These drugs have a plenty of shock resistance in medicine, have a plenty of drug treatment for heart failure, have a plenty of treatment for leukemia and cancer drugs, basic drugs have a plenty of tuberculosis, AIDS."
The issue has drawn high attention from senior leaders, says Mr Chen. |
